← Evidence map

ArticleImmunologic research2026

SALL4-targeted therapeutic peptide PEN-FFW suppresses PD-L1 and enhances CD8⁺ T cell cytotoxicity via regulating PI3K/AKT signaling in breast cancer.

Renyuan Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026

this papercites it

SALL4-targeted therapeutic peptide PEN-FFW suppresses PD-L1 and enhances CD8⁺ T cell cytotoxicity via regulating PI3K/AKT signaling in breast cancer. | Socratic